| 63 POSTER Improved antitumor activity by combining ZD644 (ZACTIMA) with rediotherapy and irinotecan in the LoVo human colorectal cancer xenograft model P Wachsberger, R Burd, T Strickler, K Kulp, A Ryan, A Dicker EJC Supplements 12 (4), 23, 2006 | | 2006 |
| Aberrant death pathways in melanoma ND Panayi, EE Mendoza, ES Breshears, R Burd Recent Advances in the Biology, Therapy and Management of Melanoma, 1-13, 2013 | 7 | 2013 |
| Absence of Crabtree effect in human melanoma cells adapted to growth at low pH: reversal by respiratory inhibitors R Burd, PR Wachsberger, JE Biaglow, ML Wahl, I Lee, DB Leeper Cancer research 61 (14), 5630-5635, 2001 | 37 | 2001 |
| Abstract# 5521: Induction of p53 dependent and independent death pathways by targeting cell specific redox systems S Sittadjody, T Thangasamy, K H Limesand, R Burd Cancer Research 69 (9_Supplement), 5521-5521, 2009 | | 2009 |
| Abstract# 5523: Mechanisms of chemosensitization in melanoma by the bioflavonoid Quercetin T Thangasamy, S Sittadjody, V M Radhakrishnan, K H. Limesand, R Burd Cancer Research 69 (9_Supplement), 5523-5523, 2009 | | 2009 |
| Application of Radiotherapy and Chemotherapy Protocols to Pre‐Clinical Tumor Models R Burd, P Wachsberger Current Protocols in Pharmacology 38 (1), 14.7. 1-14.7. 24, 2007 | 4 | 2007 |
| Autophagy correlates with maintenance of salivary gland function following radiation M Morgan-Bathke, GA Hill, ZI Harris, HH Lin, AM Chibly, RR Klein, R Burd, ... Scientific reports 4 (1), 5206, 2014 | 56 | 2014 |
| Betulinic acid sensitization of low pH adapted human melanoma cells to hyperthermia PR Wachsberger, R Burd, ML Wahl, DB Leeper International journal of hyperthermia 18 (2), 153-164, 2002 | 49 | 2002 |
| Biological effects of fever-like whole body hyperthermia on anti-tumor responses and immunological activity. E Repasky, J Ostberg, R Burd, X Wang, J Subjeck JOURNAL OF LEUKOCYTE BIOLOGY, 20-20, 1999 | | 1999 |
| Biological effects of fever-like whole body hyperthermia: Immunological activity and antitumor responses RM Burd State University of New York at Buffalo, 1998 | | 1998 |
| Cell-specific redox pathways can be targeted using disulfides to induce cell death: Enhancement by low pH and quercetin S Sittadjody, T Thangasamy, J Biaglow, C Chen, R Burd Cancer Research 67 (9_Supplement), 2356-2356, 2007 | 4 | 2007 |
| Characterization of mild whole‐body hyperthermia protocols using human breast, ovarian, and colon tumors grown in severe combined immunodeficient mice EA Repasky, E Tims, M Pritchard, R Burd Infectious Diseases in Obstetrics and Gynecology 7 (1‐2), 91-97, 1999 | 25 | 1999 |
| Collection and visualization of dietary behavior and reasons for eating using Twitter M Hingle, D Yoon, J Fowler, S Kobourov, ML Schneider, D Falk, R Burd Journal of medical Internet research 15 (6), e2613, 2013 | 79 | 2013 |
| Combination of vandetanib, radiotherapy, and irinotecan in the LoVo human colorectal cancer xenograft model P Wachsberger, R Burd, A Ryan, C Daskalakis, AP Dicker International Journal of Radiation Oncology* Biology* Physics 75 (3), 854-861, 2009 | 19 | 2009 |
| Combining the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, ZD1839, with a selective cyclooxygenase (COX)-2 inhibitor, SC236, causes a cooperative … FE Rosato, A Dicker, R Burd, S Miller, S Lanza-Jacoby Journal of Surgical Research 114 (2), 274, 2003 | 1 | 2003 |
| Control of glycolytic flux by AMP-activated protein kinase in tumor cells adapted to low pH EE Mendoza, MG Pocceschi, X Kong, DB Leeper, J Caro, KH Limesand, ... Translational oncology 5 (3), 208-216, 2012 | 54 | 2012 |
| Control of glycolytic flux by AMPK and p53-mediated siganling pathways in tumor cells grown at low pH DH Leeper, EE Mendoza, J Caro, R Burd Bodine J 3, 19, 2010 | 1 | 2010 |
| Control of Glycolytic Flux by AMPK and p53-Mediated Signaling Pathways in Tumor Cells Adapted to Grow at Low pH EE Mendoza, DB Leeper Bodine Journal 3 (1), 4, 2010 | | 2010 |
| CrossRef citations Altmetric G Ubiria Central Asian Survey 32 (4), 2013 | | 2013 |
| Cyclooxygenase (COX)-2-dependent effects of the inhibitor SC236 when combined with ionizing radiation in mammary tumor cells derived from HER-2/neu mice S Lanza-Jacoby, AP Dicker, S Miller, FE Rosato, JT Flynn, SN Lavorgna, ... Molecular Cancer Therapeutics 3 (4), 417-424, 2004 | 32 | 2004 |
